| Synonyms: | |
| Status: | Approved |
| Entry Type: | Cell |
| Molecule Category: | UKNOWN |
| ATC: | L01XX71 |
| UNII: | Q6C9WHR03O |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-lymphocyte antigen CD19 binding agent | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 2 | D015456 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Leukemia, Lymphoid | 2 | D007945 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Pancreatic Neoplasms | 0 | D010190 | ClinicalTrials |
| Hodgkin Disease | 0 | D006689 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3301574 |
| FDA SRS | Q6C9WHR03O |
CONTENTS